Giuseppe Maina Selected Research

Aftercare (After-Treatment)

11/2023	Nationwide consensus on the clinical management of treatment-resistant depression in Italy: a Delphi panel.
1/2020	Symptomatic and functional outcomes after treatment with paliperidone palmitate 3-month formulation for 52 weeks in patients with clinically stable schizophrenia.
1/2019	Five-year follow-up of first-episode depression treated with psychodynamic psychotherapy or antidepressants.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Giuseppe Maina Research Topics

Disease

34	Bipolar Disorder (Manic Depressive Psychosis) 01/2024 - 04/2007
17	Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive) 12/2022 - 06/2002
12	Schizophrenia (Dementia Praecox) 01/2023 - 04/2015
12	Major Depressive Disorder (Major Depressive Disorders) 03/2021 - 01/2007
12	Mania (Manias) 01/2020 - 04/2007
11	Psychotic Disorders (Schizoaffective Disorder) 01/2024 - 01/2010
8	Mental Disorders (Mental Disorder) 04/2023 - 09/2014
7	Depressive Disorder (Melancholia) 04/2024 - 01/2005
5	Treatment-Resistant Depressive Disorder 11/2023 - 05/2013
5	Weight Gain 11/2016 - 10/2004
4	Mood Disorders (Mood Disorder) 01/2018 - 05/2010
4	Metabolic Syndrome (Dysmetabolic Syndrome X) 06/2016 - 04/2012
3	Abdominal Obesity 03/2013 - 07/2008
3	Hypertension (High Blood Pressure) 03/2013 - 07/2008
3	Hyperglycemia 03/2013 - 07/2008
2	Tics (Tic) 12/2022 - 08/2009
2	Hyperparathyroidism 01/2015 - 11/2013
2	Anxiety Disorders (Anxiety Disorder) 04/2008 - 10/2004
1	Substance-Induced Psychoses (Psychoses, Substance Induced) 01/2024
1	Inflammation (Inflammations) 12/2023
1	Drug-Related Side Effects and Adverse Reactions 11/2023
1	Serotonin Syndrome (Syndrome, Serotonin) 11/2023
1	Rare Diseases (Rare Disease) 04/2023
1	Acromegaly 04/2023
1	Deglutition Disorders (Dysphagia) 01/2023
1	Emotional Exhaustion 01/2023
1	Tic Disorders (Tic Disorder) 12/2022
1	Trichotillomania 01/2021
1	Hoarding Disorder 01/2021
1	Excoriation Disorder 01/2021
1	Substance-Related Disorders (Drug Abuse) 01/2021
1	Infections 11/2020
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 11/2020
1	Psychomotor Agitation (Akathisia) 11/2020
1	Insulin Resistance 01/2020
1	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 12/2019
1	Neurodevelopmental Disorders 11/2019
1	Disease Progression 01/2019

Drug/Important Bio-Agent (IBA)

22	Antipsychotic Agents (Antipsychotics)IBA 01/2024 - 01/2003
13	Antidepressive Agents (Antidepressants)IBA 04/2024 - 01/2002
11	LithiumIBA 12/2023 - 04/2007
9	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 12/2020 - 01/2002
7	Aripiprazole (Abilify)FDA Link 01/2024 - 09/2009
6	Polytetrafluoroethylene (Teflon)FDA Link 01/2023 - 11/2021
6	N- ((2,3- dihydro- 1,4- benzodioxin- 2- yl)methyl)- 5- methoxy- 1H- indole- 3- ethanamineIBA 01/2019 - 01/2005
5	Valproic Acid (Depakote)FDA LinkGeneric 11/2022 - 04/2007
4	CannabinoidsIBA 01/2024 - 05/2010
4	3,4-methylenedioxyethamphetamine (MDEA)IBA 01/2022 - 08/2009
4	Olanzapine (Zyprexa)FDA Link 09/2014 - 04/2007
4	Triglycerides (Triacylglycerol)IBA 03/2013 - 07/2008
3	cariprazineIBA 01/2024 - 01/2022
3	Lurasidone Hydrochloride FDA Link 01/2024 - 11/2022
3	Paliperidone Palmitate FDA Link 01/2023 - 06/2016
3	LipidsIBA 01/2020 - 04/2012
2	Serotonin (5 Hydroxytryptamine)IBA 11/2023 - 01/2013
2	Biomarkers (Surrogate Marker)IBA 10/2023 - 01/2019
2	Proteins (Proteins, Gene)FDA Link 08/2023 - 12/2018
2	Risperidone (Risperdal Consta)FDA LinkGeneric 01/2023 - 05/2008
2	EsketamineIBA 01/2023 - 12/2022
2	Dronabinol (THC)FDA LinkGeneric 01/2023 - 01/2023
2	AntibodiesIBA 11/2020 - 08/2009
2	HDL CholesterolIBA 01/2020 - 03/2013
2	Anticonvulsants (Antiepileptic Drugs)IBA 09/2015 - 05/2011
2	CalciumIBA 01/2015 - 11/2013
2	asenapine FDA Link 09/2014 - 08/2014
2	Lamotrigine (Lamictal)FDA LinkGeneric 05/2011 - 04/2008
2	Clomipramine (Anafranil)FDA LinkGeneric 10/2004 - 11/2002
2	Sertraline (Zoloft)FDA LinkGeneric 10/2004 - 06/2002
1	brexpiprazoleIBA 01/2024
1	Lysergic Acid Diethylamide (LSD)IBA 01/2024
1	AmphetaminesIBA 01/2024
1	Cocaine (Cocaine HCl)IBA 01/2024
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 12/2023
1	Nerve Growth Factors (Neurotrophins)IBA 08/2023
1	Insulin-Like Growth Factor I (IGF-1)IBA 04/2023
1	Growth Hormone (Somatotropin)IBA 04/2023
1	Trazodone (Trittico)FDA LinkGeneric 01/2023
1	Immunoglobulin D (IgD)IBA 01/2023
1	Ketamine FDA LinkGeneric 01/2023
1	Pharmaceutical Sleep AidsIBA 01/2023
1	5,7,11,13-octadecatrayne-1,18-diolIBA 12/2022
1	Methamphetamine (Desoxyn)FDA LinkGeneric 01/2022
1	7,7'- dimethoxy- (4,4'- bi- 1,3- benzodioxole)- 5,5'- dicarboxylic acid dimethyl ester (BDD)IBA 01/2021
1	SaltsIBA 01/2021
1	Loxapine (Loxitane)FDA LinkGeneric 11/2020
1	SDMIBA 01/2020
1	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 12/2019
1	Vitamin D FDA LinkGeneric 01/2019
1	Messenger RNA (mRNA)IBA 12/2018
1	Insulin-Like Growth Factor Binding Protein 2IBA 12/2018
1	vasectrin II (VS II)IBA 03/2018
1	Tryptophan (L-Tryptophan)FDA Link 01/2018
1	Liraglutide FDA Link 01/2018

Therapy/Procedure

18	Therapeutics 10/2023 - 01/2005
7	Drug Therapy (Chemotherapy) 04/2024 - 01/2007
6	Injections 01/2023 - 01/2018
3	Aftercare (After-Treatment) 11/2023 - 01/2019
1	Treatment Delay 10/2021
1	Operative Surgical Procedures 01/2020
1	Precision Medicine 01/2019